India’s copycat drugmakers gear up to offer cheaper weight-loss drugs
Expiry of Novo Nordisk’s UK patent for Saxenda seen as offering a ‘dry run’ for future generic versions of Ozempic
Read More from the Global Wellness News ™
- First Japanese “onsen,” bath house where many patrons relax naked together in mineral-rich water, opening in U.S.
- ‘They want something different’: Two reports predict a big shift in travel behavior in 2025